Companies
- Companies
- Company details
Ipsat Therapies
Summary
Ipsat Therapies offers IPSAT(TM), which is a recombinant enzyme, which inactivates the excess unabsorbed harmful antibiotic in intestine and thus maintains a normal intestinal microflora.The company's strategy is to develop its products to the proof of concept stage and is willing to establish partnerships with interested parties.
R&D
To view this information, you must subscribe to Pharmalicensing Intelligence.
Senior management
To view this information, you must subscribe to Pharmalicensing Intelligence.
Board of directors
To view this information, you must subscribe to Pharmalicensing Intelligence.
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 26 pages - $600
Jul 2010 - 17 pages - $750
Aug 2009 - $15,200
Aug 2010 - $15,200
Jan 2011 - 6 pages - $500
Dec 2010 - 5 pages - $500
Feb 2011 - 6 pages - $500
Nov 2010 - 38 pages - $500
Oct 2009 - $15,200
Jan 2010 - $15,200
Contact details
To view this information, you must subscribe to Pharmalicensing Intelligence.
Head office
Related companies
Related categories
- Industry sector
- Biotechnology / Human therapeutics
- Drug delivery / Oral solid
- Drug discovery
- Pharmaceutical / Prescription
- Therapeutic target
- Infectious diseases
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us